-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/XAaYbGVD_xRoMfQ-huJkJq
December 10, 2019 - associated with the development of AAA, and feedback
received from 3 key informants during the scoping phase
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
July 15, 2007 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Evidence Summary
Lipid Disorders in Children: Screening
July 15, 2007
Recommendations made by the USPSTF are independent of the U.S. government. They should…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary28/cognitive-impairment-in-older-adults-screening-2014
October 22, 2013 - A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/svy-CsBNaoaeb7wRGFvLdW
January 26, 2016 - Can phase III trial results of antidepressant
medications be generalized to clinical practice?
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
September 01, 2005 - Phase III randomized study of tamoxifen and raloxifene (STAR) for the
prevention of breast cancer. 2004
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
June 20, 2019 - HIV assays: operational characteristics (phase I)—urine and oral fluid (saliva)
specimens.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/a_x9VThjBWewPwLWsUkVav
January 01, 2015 - High-dose vitamin D(3) during intensive-phase
antimicrobial treatment of pulmonary tuberculosis: a double-blind
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/o6pGCffkVCx24mNebJGCXg
January 01, 2013 - treatment-naive patients
with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised,
multicentre phase
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screeni
July 05, 2005 - HIV assays: operational characteristics (phase I)— urine and oral fluid (saliva) specimens.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
July 05, 2005 - HIV assays: operational characteristics (phase I)— urine and oral fluid (saliva) specimens.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2sssC_CV4u5DY_rgjC-FMd
February 01, 2018 - is not a screening test (i.e., staging, prognostic testing)
* Assigned at abstract and full-text phase
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9Hht_QpMB4gQg26rTpcaN
November 01, 2013 - A phase II study in patients with
Alzheimer’s disease to assess the preliminary efficacy and maximum
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16768/ovarian-cancer-final-evid-review/pdf
February 01, 2018 - is not a screening test (i.e., staging, prognostic testing)
* Assigned at abstract and full-text phase
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/CW23r2jqogvTG2_-kBjRxH
January 01, 2007 - Screening and Treatment for Hypercholesterolemia in Children and Adolescents: Systematic Evidence Review
1
Screening and Treatment for Hypercholesterolemia in Children and
Adolescents:
Systematic Evidence Review for the U.S. Preventive Services Task Force
Elizabeth M. Haney, MD (1, 2)
Laurie Hoyt H…